H. Lundbeck A/S (Lundbeck) today announced that the last patient has been randomized in DEEp SEA (NCT06660394), a global Phase III clinical trial evaluating the efficacy, safety and tolerability of ...
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results